Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALOGLIPTIN vs LINAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALOGLIPTIN vs LINAGLIPTIN: Safety Overview

Metric ALOGLIPTIN LINAGLIPTIN
Total FAERS Reports 1,385 7,762
Deaths Reported 122 726
Death Rate 8.8% 9.4%
Hospitalizations 567 2,794
Average Patient Age 69.0 yrs 70.2 yrs
% Female Patients 41.0% 51.8%
FDA Approval Date Jan 25, 2013 Aug 31, 2021
Manufacturer Padagis Israel Pharmaceuticals Ltd Novadoz Pharmaceuticals LLC
Route ORAL ORAL
Marketing Status Prescription Prescription